Elmhurst Drugs is an authorized DME supplier for medicare equipments and products.
Elmhurst Drugs is a Community/Retail Pharmacy in Elmhurst, New York. This pharmacy is owned and operated by Benjamin Pharmacy Corp. It is located at 84 04 Broadway, Elmhurst and it's customer support contact number is 718-457-7884. The authorized person of Elmhurst Drugs is Jorge Restnepo, RPH who is President of the pharmacy and his contact number is 718-457-7884. Active license number of Elmhurst Drugs is 019975 for Community/Retail Pharmacy in New York. Elmhurst Drugs accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Elmhurst Drugs is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Elmhurst Drugs type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Elmhurst Drugs
Type:
Community/Retail Pharmacy
Location:
84 04 Broadway, Elmhurst, New York, 11373-5793
Phone:
718-457-7884
Fax:
718-457-2322
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Jorge Restnepo
Credentials:
RPH
Position:
President
Contact Number:
718-457-7884
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1134296320
NPI Enumeration Date:
30 Nov, 2006
NPI Last Update On:
08 Jan, 2016
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elmhurst Drugs are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
019975
New York
Primary
Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2065536
Other
Pk
01599715
Medicaid
New York
Medicare Enrollment:
Elmhurst Drugs is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
7517085657
O20100930097350
Benjamin Pharmacy Corp
DME SUPPLIER - PHARMACY
Products Available:
Elmhurst Drugs has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Breast Prostheses & Accessories
Canes & Crutches
Enteral Equipment And/or Supplies
Enteral Nutrients
Heat & Cold Applications
Nebulizer Equipment & Supplies
Orthoses: Off-the-shelf
Ostomy Supplies
Transcutaneous Electrical Nerve Stimulators (tens) Units
Urological Supplies
Walkers
Wheelchair Seating/cushions
Wheelchairs & Accessories: Standard Manual
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
84 04 Broadway, Elmhurst, New York
Zip:
11373-5793
Phone Number:
718-457-7884
Fax Number:
718-457-2322
Patients can reach Elmhurst Drugs at 84 04 Broadway, Elmhurst, New York or can call on customer care at 718-457-7884.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.